T. Shaw3 L, Hariprasad I, V. Messner L, A. Bansal C, A. Schechet S, Pérez J. Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature. BOHR International Journal of Current Research in Optometry and Ophthalmology [Internet]. 2022 Oct. 7 [cited 2024 May 19];1(1):74–79. Available from: https://journals.bohrpub.com/index.php/bijcroo/article/view/108